EVER proteins, key elements of the natural anti-human papillomavirus barrier, are regulated upon T-cell activation

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Lazarczyk, Maciej ^a,b,c   Dalard, Cécile ^a,b,c   Hayder, Myriam ^a,b,c   Dupre, Loïc ^a,b,c   Pignolet, Béatrice ^a,b,c   Majewski, Slawomir ^d   Vuillier, Francoise ^e   Favre, Michel ^e   Liblau, Roland S ^a,b,c  

^a INSERM   (France)

^b CNRS   (France)

^c UNIVERSITÉ PAUL SABATIER   (France)

^d MEDICAL UNIVERSITY OF WARSAW   (Poland)

^e INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EVER1 PROTEIN; EVER2 PROTEIN; PROTEIN; UNCLASSIFIED DRUG; ZINC ION;

ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; EPIDERMODYSPLASIA VERRUCIFORMIS; EVER GENE; FEMALE; GENE; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENODERMATOSIS; LYMPHOCYTE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PAPILLOMA VIRUS; SKIN CARCINOMA; T LYMPHOCYTE ACTIVATION;

ANIMALS; BASE SEQUENCE; CELL LINE; DNA PRIMERS; FEMALE; HUMANS; LYMPHOCYTE ACTIVATION; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION; T-LYMPHOCYTES;

HUMAN PAPILLOMAVIRUS; MURINAE; PAPILLOMAVIRIDAE;

EID: 84863008351     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039995     Document Type: Article

References (44)

1. Wang SS, Hildesheim A, (2003) Chapter 5: Viral and host factors in human papillomavirus persistence and progression. J Natl Cancer Inst Monogr 31: 35-40.
2. Schiffman M, Kjaer SK, (2003) Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia. J Natl Cancer Inst Monogr 31: 14-19.
3. Lazarczyk M, Favre M, (2008) Role of Zn2+ ions in host-virus interactions. J Virol 82: 11486-11494.
4. Lazarczyk M, Cassonnet P, Pons C, Jacob Y, Favre M, (2009) The EVER proteins as a natural barrier against papillomaviruses: a new insight into the pathogenesis of human papillomavirus infections. Microbiol Mol Biol Rev 73: 348-370.
5. Majewski S, Jablonska S, Orth G, (1997) Epidermodysplasia verruciformis. Immunological and nonimmunological surveillance mechanisms: role in tumor progression. Clin Dermatol 15: 321-334.
6. Orth G, (2006) Genetics of epidermodysplasia verruciformis: Insights into host defense against papillomaviruses. Semin Immunol 18: 362-374.
7. Ramoz N, Rueda LA, Bouadjar B, Favre M, Orth G, (1999) A susceptibility locus for epidermodysplasia verruciformis, an abnormal predisposition to infection with the oncogenic human papillomavirus type 5, maps to chromosome 17qter in a region containing a psoriasis locus. J Invest Dermatol 112: 259-263.
8. Ramoz N, Taïeb A, Rueda LA, Montoya LS, Bouadjar B, et al. (2000) Evidence for a nonallelic heterogeneity of epidermodysplasia verruciformis with two susceptibility loci mapped to chromosome regions 2p21-p24 and 17q25. J Invest Dermatol 114: 1148-1153.
9. Ramoz N, Rueda LA, Bouadjar B, Montoya LS, Orth G, et al. (2002) Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat Genet 32: 579-581.
10. Orth G, (2008) Host defenses against human papillomaviruses: lessons from epidermodysplasia verruciformis. D Beutler ed, Immunology, Phenotype first: how mutations have established new principles and pathways in immunology. Current Topics in Microbiology and Immunology. Springer-Verlag Berlin Heidelberg pp. 59-83.
11. Lazarczyk M, Pons C, Mendoza JA, Cassonnet P, Jacob Y, et al. (2008) Regulation of cellular zinc balance as a potential mechanism of EVER-mediated protection against pathogenesis by cutaneous oncogenic human papillomaviruses. J Exp Med 205: 35-42.
12. Seo SR, Chong SA, Lee SI, Sung JY, Ahn YS, et al. (2001) Zn2+-induced ERK activation mediated by reactive oxygen species causes cell death in differentiated PC12 cells. J Neurochem 78: 600-610.
13. Kim YM, Reed W, Wu W, Bromberg PA, Graves LM, et al. (2006) Zn2+-induced IL-8 expression involves AP-1, JNK, and ERK activities in human airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 290: L1028-L1035.
14. Barthel A, Ostrakhovitch EA, Walter PL, Kampkötter A, Klotz LO, (2007) Stimulation of phosphoinositide 3-kinase/Akt signaling by copper and zinc ions: mechanisms and consequences. Arch Biochem Biophys 463: 175-182.
15. Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, et al. (2004) A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci U S A 101: 6062-6067.
16. Glinski W, Jablonska S, Langner A, Obalek S, Haftek M, et al. (1976) Cell-mediated immunity in epidermodysplasia verruciformis. Dermatologica 153: 218-227.
17. Pyrhönen S, Jablonska S, Obalek S, Kuismanen E, (1980) Immune reactions in epidermodysplasia verruciformis. Br J Dermatol 102: 247-254.
18. Haftek M, Jablonska S, Orth G, (1985) Specific cell-mediated immunity in patients with epidermodysplasia verruciformis and plane warts. Dermatologica 170: 213-220.
19. Rogers HD, Macgregor JL, Nord KM, Tyring S, Rady P, et al. (2009) Acquired epidermodysplasia verruciformis. J Am Acad Dermatol 60: 315-320.
20. Kawai K, Egawa N, Kiyono T, Kanekura T, (2009) Epidermodysplasia-verruciformis-like eruption associated with gamma-papillomavirus infection in a patient with adult T-cell leukemia. Dermatology 219: 274-278.
21. Barzegar C, Paul C, Saiag P, Cassenot P, Bachelez H, et al. (1998) Epidermodysplasia verruciformis-like eruption complicating human immunodeficiency virus infection. Br J Dermatol 139: 122-127.
22. Tobin E, Rohwedder A, Holland SM, Philips B, Carlson JA, (2003) Recurrent 'sterile' verrucous cyst abscesses and epidermodysplasia verruciformis-like eruption associated with idiopathic CD4 lymphopenia. Br J Dermatol 149: 627-633.
23. Laffort C, Le Deist F, Favre M, Caillat-Zucman S, Radford-Weiss I, et al. (2004) Severe cutaneous papillomavirus disease after haemopoietic stem-cell transplantation in patients with severe combined immune deficiency caused by common gammac cytokine receptor subunit or JAK-3 deficiency. Lancet 363: 2051-2054.
24. Prawer SE, Pass F, Vance JC, Greenberg LJ, Yunis EJ, et al. (1977) Depressed immune function in epidermodysplasia verruciformis. Arch Dermatol 113: 495-499.
25. Palmiter RD, Findley SD, (1995) Cloning and functional characterization of a mammalian zinc transporter that confers resistance to zinc. EMBO J 14: 639-649.
26. Langmade SJ, Ravindra R, Daniels PJ, Andrews GK, (2000) Transcription factor MTF-1 mediates metal regulation of the mouse ZnT1 gene. J Biol Chem 275: 34803-34809.
27. Saxena A, Bauer J, Scheikl T, Zappulla J, Audebert M, et al. (2008) Cutting edge: Multiple sclerosis-like lesions induced by effector CD8 T cells recognizing a sequestered antigen on oligodendrocytes. J Immunol 181: 1617-1621.
28. Vizler C, Bercovici N, Heurtier A, Pardigon N, Goude K, et al. (2000) Relative diabetogenic properties of islet-specific Tc1 and Tc2 cells in immunocompetent hosts. J Immunol 165: 6314-6321.
29. Eide DJ, (2006) Zinc transporters and the cellular trafficking of zinc. Biochim Biophys Acta 1763: 711-722.
30. Kaler P, Prasad R, (2007) Molecular cloning and functional characterization of novel zinc transporter rZip10 (Slc39a10) involved in zinc uptake across rat renal brush-border membrane. Am J Physiol Renal Physiol 292: F217-F229.
31. Yu M, Lee WW, Tomar D, Pryshchep S, Czesnikiewicz-Guzik M, et al. (2011) Regulation of T cell receptor signaling by activation-induced zinc influx. J Exp Med 208: 775-85.
32. Aydemir TB, Liuzzi JP, McClellan S, Cousins RJ, (2009) Zinc transporter ZIP8 (SLC39A8) and zinc influence IFN-gamma expression in activated human T cells. J Leukoc Biol 86: 337-348.
33. Yamasaki S, Sakata-Sogawa K, Hasegawa A, Suzuki T, Kabu K, et al. (2007) Zinc is a novel intracellular second messenger. J Cell Biol 177: 637-645.
34. Kaltenberg J, Plum LM, Ober-Blöbaum JL, Hönscheid A, Rink L, et al. (2010) Zinc signals promote IL-2-dependent proliferation of T cells. Eur J Immunol 40: 1496-1503.
35. Margoshes M, Vallee BL, (1957) A cadmium protein from equine kidney cortex J Am Chem Soc 79: 4813-4814.
36. Pulido P, Kägi JH, Vallee BL, (1966) Isolation and some properties of human metallothionein. Biochemistry 5: 1768-1777.
37. Landini MM, Zavattaro E, Borgogna C, Azzimonti B, De Andrea M, et al. (2012) J Invest Dermatol 132: 1305-1308.
38. Lin RS, Rodriguez C, Veillette A, Lodish HF, (1998) Zinc is essential for binding of p56(lck) to CD4 and CD8alpha. J Biol Chem 273: 32878-32882.
39. Romir J, Lilie H, Egerer-Sieber C, Bauer F, Sticht H, et al. (2007) Crystal structure analysis and solution studies of human Lck-SH3; zinc-induced homodimerization competes with the binding of proline-rich motifs. J Mol Biol 365: 1417-1428.
40. Csermely P, Somogyi J, (1989) Zinc as a possible mediator of signal transduction in T lymphocytes. Acta Physiol Hung 74: 195-199.
41. Tanaka S, Akaishi E, Hosaka K, Okamura S, Kubohara Y, (2005) Zinc ions suppress mitogen-activated interleukin-2 production in Jurkat cells. Biochem Biophys Res Commun 335: 162-167.
42. Haase H, Rink L, (2009) Functional significance of zinc-related signaling pathways in immune cells. Annu Rev Nutr. 29: 133-52.
43. Dupré L, Aiuti A, Trifari S, Martino S, Saracco P, et al. (2002) Wiskott-Aldrich syndrome protein regulates lipid raft dynamics during immunological synapse formation. Immunity 17: 157-166.
44. Haase H, Hebel S, Engelhardt G, Rink L, (2006) Flow cytometric measurement of labile zinc in peripheral blood mononuclear cells. Anal Biochem 352: 222-230.